Literature DB >> 35831762

Recent advances in sonodynamic immunotherapy.

Hui Wang1, Guo-Qing Sui2, Zhi-Xia Sun3, Jia-Rui Du4, Yang Wang4, Zong-Hua Yue4, Han-Yu Zhang4.   

Abstract

Tumor immunotherapy has become an important means of tumor therapy by enhancing the immune response and triggering the activation of immune cells. However, currently, only a small number of patients respond to immunotherapy alone, and patients may experience immune-related adverse events (irAEs) during the course of treatment. Sonodynamic therapy (SDT) can produce cytotoxic substances to tumor tissue, induce apoptosis and enhance immunity. SDT combined with immunotherapy is considered a promising strategy for cancer treatment. In this mini review, we summarize the role of SDT in immunotherapy in recent years, including the application of SDT-triggered immunotherapy and the combination of SDT and immunotherapy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Immune; Immunotherapy; Sonodynamic therapy; Ultrasound

Year:  2022        PMID: 35831762     DOI: 10.1007/s00432-022-04190-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.322


  55 in total

1.  Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery.

Authors:  Binfan Chen; Ang Gao; Bin Tu; Yonghui Wang; Xiaolu Yu; Yingshu Wang; Yanfeng Xiu; Bing Wang; Yakun Wan; Yongzhuo Huang
Journal:  Biomaterials       Date:  2020-06-12       Impact factor: 12.479

2.  Breakthrough of the year 2013. Cancer immunotherapy.

Authors:  Jennifer Couzin-Frankel
Journal:  Science       Date:  2013-12-20       Impact factor: 47.728

3.  Nanotherapeutics interfere with cellular redox homeostasis for highly improved photodynamic therapy.

Authors:  Qian Cheng; Wuyang Yu; Jingjie Ye; Miaodeng Liu; Wenlong Liu; Chi Zhang; Cheng Zhang; Jun Feng; Xian-Zheng Zhang
Journal:  Biomaterials       Date:  2019-09-17       Impact factor: 12.479

4.  Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin.

Authors:  Sophie A Dusoswa; Jan Verhoeff; Erik Abels; Santiago P Méndez-Huergo; Diego O Croci; Lisan H Kuijper; Elena de Miguel; Valerie M C J Wouters; Myron G Best; Ernesto Rodriguez; Lenneke A M Cornelissen; Sandra J van Vliet; Pieter Wesseling; Xandra O Breakefield; David P Noske; Thomas Würdinger; Marike L D Broekman; Gabriel A Rabinovich; Yvette van Kooyk; Juan J Garcia-Vallejo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

5.  Noninvasively immunogenic sonodynamic therapy with manganese protoporphyrin liposomes against triple-negative breast cancer.

Authors:  Huaqing Chen; Lanlan Liu; Aiqing Ma; Ting Yin; Ze Chen; Ruijing Liang; Yuzhi Qiu; Mingbin Zheng; Lintao Cai
Journal:  Biomaterials       Date:  2021-01-04       Impact factor: 12.479

6.  In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes.

Authors:  N Doan; P Reher; S Meghji; M Harris
Journal:  J Oral Maxillofac Surg       Date:  1999-04       Impact factor: 1.895

7.  Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy.

Authors:  Keman Cheng; Yanping Ding; Ying Zhao; Shefang Ye; Xiao Zhao; Yinlong Zhang; Tianjiao Ji; Huanhuan Wu; Bin Wang; Gregory J Anderson; Lei Ren; Guangjun Nie
Journal:  Nano Lett       Date:  2018-04-26       Impact factor: 11.189

8.  Generation of ROS mediated by mechanical waves (ultrasound) and its possible applications.

Authors:  Walter Duco; Viviana Grosso; Daniel Zaccari; Arnaldo T Soltermann
Journal:  Methods       Date:  2016-08-16       Impact factor: 3.608

Review 9.  PD-L1 as a biomarker of response to immune-checkpoint inhibitors.

Authors:  Deborah Blythe Doroshow; Sheena Bhalla; Mary Beth Beasley; Lynette M Sholl; Keith M Kerr; Sacha Gnjatic; Ignacio I Wistuba; David L Rimm; Ming Sound Tsao; Fred R Hirsch
Journal:  Nat Rev Clin Oncol       Date:  2021-02-12       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.